SCHEMBL21702210

SCHEMBL21702210

N#Cc1ccc(-c2cccc3c2-c2c(-c4cccc(-c5nc(-c6ccccc6)nc(-c6ccccc6)n5)c4)cccc2C32c3ccccc3Sc3ccccc32)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 13/20 0.39
ABCB1 P08183 9/20 0.39
ABCC1 P33527 4/20 0.35
MEN1 O00255 2/20 0.35
ALDH1A1 P00352 2/20 0.35
CYP1A2 P05177 2/20 0.35
CYP3A4 P08684 2/20 0.35
CYP2C19 P33261 2/20 0.35
KMT2A Q03164 2/20 0.35
CLK4 Q9HAZ1 2/20 0.35
LMNA P02545 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
TSHR P16473 1/20 0.35
HSD17B10 Q99714 1/20 0.35
PDK2 Q15119 2/20 0.34
ADORA3 P0DMS8 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA1 P30542 1/20 0.33
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21702199 0.96 ABCG2 (0.39) ABCG2ABCB1ABCC1MEN1ALDH1A1
SCHEMBL21702007 0.93 ABCG2 (0.42) ABCG2ABCB1ABCC1MEN1ALDH1A1
SCHEMBL21701892 0.93 CYP1A2 (0.42) ABCG2MEN1ALDH1A1CYP1A2CYP3A4
SCHEMBL21701888 0.93 ABCG2 (0.37) ABCG2ABCB1ABCC1TSHRPDK2
SCHEMBL23257667 0.92 ABCG2 (0.36) ABCG2ABCB1ABCC1MEN1ALDH1A1
SCHEMBL21343108 0.92 ABCG2 (0.37) ABCG2ABCB1ABCC1MEN1ALDH1A1
SCHEMBL21343158 0.92 ABCG2 (0.38) ABCG2ABCB1ABCC1MEN1ALDH1A1
SCHEMBL21702004 0.92 ABCG2 (0.44) ABCG2ABCB1ABCC1MEN1ALDH1A1
SCHEMBL23256850 0.91 ABCG2 (0.35) ABCG2ABCB1ABCC1MEN1ALDH1A1
SCHEMBL23256853 0.91 ABCG2 (0.37) ABCG2ABCB1ABCC1MEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200048230-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT INCLUDING SAME LG CHEM, LTD. (KR) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200048230-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT INCLUDING SAME CRY1, CRY2, CYP1A1 ABCG2 2349/4885ABCB1 1101/4885ABCC1 1319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.